Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Systematic analysis of CD39, CD103, CD137, and PD‐1 as biomarkers for naturally occurring tumor antigen‐specific TILs

European Journal of Immunology(2021)10.1002/eji.202149329Source: DataRank Database

Systematic analysis of CD39, CD103, CD137, and PD‐1 as biomarkers for naturally occurring tumor antigen‐specific TILs is a research paper published in European Journal of Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 45 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access45 citations

Download PDF

Cite:

Linked data & code

rrid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.20)OA: bronzeTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Dalia K. Omran ORCID,Jessica Chacon ORCID,Daniel J. Powell ORCID,Monika A. Eiva ORCID

Live enrichment

PubMed:34505280 PMC:PMC8755575 OpenAlex:https://openalex.org/W3198630368

NCI NIH HHS

Grant: P50 CA228991

NCI NIH HHS

Grant: T32 CA009140

National Institutes of Health

Grant: 5P50CA228991-02

SPORE in Ovarian Cancer

FWCI

2.20

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: https://www.biorxiv.org/about/FAQ#license

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/eji.202149329

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/eji.202149329

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/eji.202149329

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/eji.202149329

journalhttps://doi.org/10.1002/eji.202149329

Fields of Study

Immune Cell Function and InteractionCancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses0301 basic medicine03 medical and health sciences

MeSH Terms

ApyraseFemaleHumansInterferon-gammaOvarian NeoplasmsBiomarkers, TumorAntigens, CDLymphocytes, Tumor-InfiltratingIntegrin alpha ChainsTumor Necrosis Factor Receptor Superfamily, Member 9Programmed Cell Death 1 Receptor

Keywords

CD137Tumor-infiltrating lymphocytesCancer researchBiologyEffectorImmunotherapyT cellEx vivoFlow cytometryBTLAImmune systemImmunologyIn vivoPD-1Cd103Cd39Ovarian NeoplasmsApyraseProgrammed Cell Death 1 ReceptorInterferon-gammaTumor Necrosis Factor Receptor Superfamily, Member 9Lymphocytes, Tumor-InfiltratingAntigens, CDBiomarkers, TumorHumansFemaleIntegrin alpha Chains

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Systematic analysis of CD39, CD103, CD137, and PD‐1 as biomarkers for naturally occurring tumor antigen‐specific TILs

FAIR Checklist

Authors (4)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)